<DOC>
	<DOCNO>NCT00987207</DOCNO>
	<brief_summary>Primary objective : To evaluate efficacy cyclosporin A administration induce cardioprotection valvular surgery .</brief_summary>
	<brief_title>Pharmacological Postconditioning During Aortic Valvular Surgery</brief_title>
	<detailed_description />
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Male female , schedule aortic valvular surgery ; 18 year age old . Combined valvular coronary surgery ; Significant coronary artery stenosis ( upper 70 % ) ; Left ventricular dysfunction ( ejection fraction &lt; 40 % ) ; Emergency surgery and/or infectious endocarditis ; Known cyclosporin hypersensitivity ; History know recent immunosuppression ( &lt; 6 month ) : cancer , lymphoma , positive serology HIV , hepatitis ; Renal insufficiency ( creatininaemia &gt; 150 Âµmol/l ) ; Hepatic insufficiency ( prothrombin time &lt; 50 % ) ; Uncontrolled arterial hypertension define systolic arterial pressure &gt; 180 mm Hg ; Women child bear potential , pregnant efficient contraception ; Patients treat nicorandil , sulfonylurea rosuvastatine ; Patients judicial control .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Postconditioning</keyword>
	<keyword>cyclosporine A</keyword>
	<keyword>myocardial ischemia</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>aortic valvulopathy</keyword>
</DOC>